Gur Roshwalb

Gur Roshwalb, M.D., never be worried of any challenge. When Dr Roshwalb, CEO at Akari Therapeutics Plc, saw once in a lifetime opportunity to develop a fully financed but struggling U.S. biotech company. He made this possible by merging it with a cash-strapped British company and a very promising new drug therapy for those patients that has rare conditions.